Clinical Trials Directory

Trials / Completed

CompletedNCT01181414

Spanish Atrial Fibrillation And Resynchronization Study

Phase 4. Study of Cardiac Resynchronization Therapy in Patients With Permanent Atrial Fibrillation.

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the present study is to compare the response to cardiac resynchronization therapy (CRT) in patients with chronic advanced heart failure and permanent atrial fibrillation (AF) depending on atrio ventricular junction (AVJ) is ablated or not.

Detailed description

Cardiac resynchronization therapy (CRT) improves the functional capacity and the quality of life and reduces the mortality of patients with dilated cardiomyopathy, low ejection fraction and wide QRS. Only 2% of patients included in CRT randomized trials were in AF. To obtain a good response to CRT, percentage \>90% of ventricular pacing must be obtained. Based on observational studies, current guidelines of CRT recommend the atrio ventricular junction (AVJ) ablation in those patients with permanent atrial fibrillation.

Conditions

Interventions

TypeNameDescription
PROCEDUREAtrio ventricular junction ablation with radio-frequencyAtrioventricular junction ablation by using radiofrequency energy.
DRUGBeta blocker/digoxine/amiodaroneVentricular rate control by using drug treatment.

Timeline

Start date
2010-10-01
Primary completion
2014-11-01
Completion
2015-01-01
First posted
2010-08-13
Last updated
2015-03-10

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT01181414. Inclusion in this directory is not an endorsement.